Dexamethasone Acetate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

73 API Suppliers, 26 USDMF, 9 CEP/COS, 6 JDMF, 2 EU WC, 7 KDMF, 26 NDC API, 2 VMF, 50 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

218 Drugs in Development

218 Drugs in Development

INTERMEDIATES

2 API Suppliers

2 API Suppliers

FINISHED DOSAGE FORMULATIONS

361 FDF Dossiers, 130 FDA Orange Book, 113 Europe, 27 Canada, 10 Australia, 17 South Africa, 64 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OPHTHALMIC - 0.1%, SUSPENSION/DROPS;OTIC - 0.3%;0.1%, OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM, SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3%, OINTMENT;OPHTHALMIC - 0.1%;0.3%, SUSPENSION/DROPS;OPHTHALMIC - 0.05%;0.3%, TABLET;ORAL - 1.5MG, TABLET;ORAL - 0.5MG, TABLET;ORAL - 4MG, TABLET;ORAL - 0.75MG, TABLET;ORAL - 2MG, SOLUTION;ORAL - 0.5MG/5ML, ELIXIR;ORAL - 0.5MG/5ML, TABLET;ORAL - 1MG, TABLET;ORAL - 6MG

RELATED EXCIPIENT COMPANIES

4 Rochem International Inc, 7 SPI Pharma, 8 DKSH, 2 Jai Radhe Sales, 1 Pharm-RX Chemical, 13 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 15 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 10 Corel Pharma Chem, 1 Curia, 6 DFE Pharma, 3 Finar, 8 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 30 Roquette, 15 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

70 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 31 Direct Compression, 28 Thickeners and Stabilizers, 25 Solubilizers, 22 Controlled & Modified Release, 20 Parenteral, 20 Topical, 19 Film Formers & Plasticizers, 19 Disintegrants & Superdisintegrants, 17 Co-Processed Excipients, 17 Taste Masking, 16 Granulation, 13 Lubricants & Glidants, 9 Chewable & Orodispersible Aids, 9 Rheology Modifiers, 7 Emulsifying Agents, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 264 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 110 Finished Drug Prices, 6 Annual Reports

MARKET PLACE

61 APIs, 59 FDF Dossiers

PATENTS & EXCLUSIVITIES

16 US Patents, 3 US Exclusivities, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

8 EDQM, 2 USP, 2 JP, 8 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 50065 / DOSAGE - OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
DEXAMETHASONE(UNII: 7S5I7G3JQL) (DEXAMETHASONE - UNII:7S5I7G3JQL)	DEXAMETHASONE	1mg in 1
NEOMYCIN SULFATE(UNII: 057Y626693) (NEOMYCIN - UNII:I16QD7X297)	NEOMYCIN	3.5mg in 1
POLYMYXIN B SULFATE(UNII: 19371312D4) (POLYMYXIN B - UNII:J2VZ07J96K)	POLYMYXIN B	10000[iU] in 1

Inactive Ingredients

Ingredient Name	Major Pharmaceuticals	Preferred Pharmaceuticals Inc.	Preferred Pharmaceuticals, Inc	Fera Pharmaceuticals	Preferred Pharmaceuticals, Inc.	Putney, Inc.
LANOLIN(7EV65EAW6H)
METHYLPARABEN(A2I8C7HI9T)
MINERAL OIL(T5L8T28FGP)
PETROLATUM(4T6H12BN9U)
PROPYLPARABEN(Z8IX2SC1OH)

Drug Product Composition: Dexamethasone Acetate